Article
Small molecule inhibitors of Late SV40 Factor (LSF) abrogate hepatocellular carcinoma (HCC): Evaluation using an endogenous HCC model.
Oncotarget - 22 Sept 2015
Rajasekaran Devaraja, Siddiq Ayesha, Willoughby Jennifer L S, Biagi Jessica M, Christadore Lisa M, Yunes Sarah A, Gredler Rachel, Jariwala Nidhi, Robertson Chadia L, Akiel Maaged A, Shen Xue-Ning, Subler Mark A, Windle Jolene J, Schaus Scott E, Fisher Paul B, Hansen Ulla, Sarkar Devanand
Abstract excerpt
Hepatocellular carcinoma (HCC) is a lethal malignancy with high mortality and poor prognosis. Oncogenic transcription factor Late SV40 Factor (LSF) plays an important role in promoting HCC. A small molecule inhibitor of LSF, Factor Quinolinone Inhibitor 1 (FQI1), significantly inhibited human HCC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
